These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 21849193)

  • 1. Serum amino acid levels as a biomarker for renal cell carcinoma.
    Mustafa A; Gupta S; Hudes GR; Egleston BL; Uzzo RG; Kruger WD
    J Urol; 2011 Oct; 186(4):1206-12. PubMed ID: 21849193
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The predictive and prognostic values of serum amino acid levels for clear cell renal cell carcinoma.
    Zhang F; Ma X; Li H; Guo G; Li P; Li H; Gu L; Li X; Chen L; Zhang X
    Urol Oncol; 2017 Jun; 35(6):392-400. PubMed ID: 28188089
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of serum immunosuppressive acidic protein in renal cell carcinoma].
    Matsumoto K; Iwamura M; Muramoto M; Suyama K; Tabata K; Minei S; Hirai S; Baba S
    Nihon Hinyokika Gakkai Zasshi; 2002 May; 93(4):548-54. PubMed ID: 12056039
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serum immunosuppressive acidic protein as a tumor marker for renal cell carcinoma.
    Igarashi T; Murakami S; Isaka S; Okano T; Shimazaki J; Matsuzaki O
    Eur Urol; 1991; 19(4):332-5. PubMed ID: 1915542
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Combination of serum histidine and plasma tryptophan as a potential biomarker to detect clear cell renal cell carcinoma.
    Lee HO; Uzzo RG; Kister D; Kruger WD
    J Transl Med; 2017 Apr; 15(1):72. PubMed ID: 28385150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Serum carbonic anhydrase 9 level is associated with postoperative recurrence of conventional renal cell cancer.
    Li G; Feng G; Gentil-Perret A; Genin C; Tostain J
    J Urol; 2008 Aug; 180(2):510-3; discussion 513-4. PubMed ID: 18550116
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Possibility of multivariate function composed of plasma amino acid profiles as a novel screening index for non-small cell lung cancer: a case control study.
    Maeda J; Higashiyama M; Imaizumi A; Nakayama T; Yamamoto H; Daimon T; Yamakado M; Imamura F; Kodama K
    BMC Cancer; 2010 Dec; 10():690. PubMed ID: 21176209
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prognostic analysis of postoperative clinically nonmetastatic renal cell carcinoma.
    Shao Y; Xiong S; Sun G; Dou W; Hu X; Yang W; Lia T; Deng S; Wei Q; Zeng H; Li X
    Cancer Med; 2020 Feb; 9(3):959-970. PubMed ID: 31840431
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Significance of amyloid A immunoexpression in the prognosis of renal cell carcinoma.
    Oz Atalay F; Aytac Vuruskan B; Vuruskan H
    APMIS; 2016 Apr; 124(4):257-62. PubMed ID: 26750935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Predictive values of acute phase reactants, basic fetoprotein, and immunosuppressive acidic protein for staging and survival in renal cell carcinoma.
    Miyata Y; Koga S; Nishikido M; Noguchi M; Kanda S; Hayashi T; Saito Y; Kanetake H
    Urology; 2001 Aug; 58(2):161-4. PubMed ID: 11489689
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Unique protein expression signatures of survival time in kidney renal clear cell carcinoma through a pan-cancer screening.
    Han G; Zhao W; Song X; Kwok-Shing Ng P; Karam JA; Jonasch E; Mills GB; Zhao Z; Ding Z; Jia P
    BMC Genomics; 2017 Oct; 18(Suppl 6):678. PubMed ID: 28984208
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Interleukin-11 receptor predicts post-operative clinical outcome in patients with early-stage clear-cell renal cell carcinoma.
    Pan D; Xu L; Liu H; Zhang W; Zhu Y; Xu J; Gu J
    Jpn J Clin Oncol; 2015 Feb; 45(2):202-9. PubMed ID: 25420690
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MicroRNA profile in stage I clear cell renal cell carcinoma predicts progression to metastatic disease.
    Moynihan MJ; Sullivan TB; Burks E; Schober J; Calabrese M; Fredrick A; Kalantzakos T; Warrick J; Canes D; Raman JD; Rieger-Christ K
    Urol Oncol; 2020 Oct; 38(10):799.e11-799.e22. PubMed ID: 32534961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Use of serum gamma-enolase and aldolase A in combination as markers for renal cell carcinoma.
    Takashi M; Sakata T; Kato K
    Jpn J Cancer Res; 1993 Mar; 84(3):304-9. PubMed ID: 8486529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Renal cell carcinoma: prognostic significance of incidentally detected tumors.
    Tsui KH; Shvarts O; Smith RB; Figlin R; de Kernion JB; Belldegrun A
    J Urol; 2000 Feb; 163(2):426-30. PubMed ID: 10647646
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictive value of single-nucleotide polymorphism signature for recurrence in localised renal cell carcinoma: a retrospective analysis and multicentre validation study.
    Wei JH; Feng ZH; Cao Y; Zhao HW; Chen ZH; Liao B; Wang Q; Han H; Zhang J; Xu YZ; Li B; Wu JT; Qu GM; Wang GP; Liu C; Xue W; Liu Q; Lu J; Li CX; Li PX; Zhang ZL; Yao HH; Pan YH; Chen WF; Xie D; Shi L; Gao ZL; Huang YR; Zhou FJ; Wang SG; Liu ZP; Chen W; Luo JH
    Lancet Oncol; 2019 Apr; 20(4):591-600. PubMed ID: 30880070
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Postoperative prognostic model for patients with clear cell renal cell carcinoma in a Chinese population.
    Zhu Y; Zhao YR; Yang XF; Wei MT; Niu YJ; Chang JW; Wang AX; Liang X
    Int J Urol; 2019 Jun; 26(6):624-629. PubMed ID: 30861595
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Is imagery distinctive in papillary renal cell carcinoma subtypes?
    Karray O; Ayed H; Saadi A; Zaghbib S; Henchir S; Cherif A; Ben Miled A; Chakroun M; Bouzouita A; Derouiche A; Ben Slama R; Chebil M
    Tunis Med; 2020 Feb; 98(2):131-137. PubMed ID: 32395802
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Vascular cell adhesion molecule 1 predicts cancer-free survival in clear cell renal carcinoma patients.
    Shioi K; Komiya A; Hattori K; Huang Y; Sano F; Murakami T; Nakaigawa N; Kishida T; Kubota Y; Nagashima Y; Yao M
    Clin Cancer Res; 2006 Dec; 12(24):7339-46. PubMed ID: 17189405
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and verification of a nomogram for prediction of recurrence-free survival in clear cell renal cell carcinoma.
    Chen Y; Jiang S; Lu Z; Xue D; Xia L; Lu J; Wang H; Xu L; Li L; Li G
    J Cell Mol Med; 2020 Jan; 24(2):1245-1255. PubMed ID: 31782902
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.